Literature DB >> 26199357

Facile Discovery of Cell-Surface Protein Targets of Cancer Cell Aptamers.

Tao Bing1, Dihua Shangguan2, Yinsheng Wang3.   

Abstract

Cancer biomarker discovery constitutes a frontier in cancer research. In recent years, cell-binding aptamers have become useful molecular probes for biomarker discovery. However, there are few successful examples, and the critical barrier resides in the identification of the cell-surface protein targets for the aptamers, where only a limited number of aptamer targets have been identified so far. Herein, we developed a universal SILAC-based quantitative proteomic method for target discovery of cell-binding aptamers. The method allowed for distinguishing specific aptamer-binding proteins from nonspecific proteins based on abundance ratios of proteins bound to aptamer-carrying bait and control bait. In addition, we employed fluorescently labeled aptamers for monitoring and optimizing the binding conditions. We were able to identify and validate selectin L and integrin α4 as the protein targets for two previously reported aptamers, Sgc-3b and Sgc-4e, respectively. This strategy should be generally applicable for the discovery of protein targets for other cell-binding aptamers, which will promote the applications of these aptamers.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26199357      PMCID: PMC4597145          DOI: 10.1074/mcp.M115.051243

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  35 in total

1.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS.

Authors:  Andrew Thompson; Jürgen Schäfer; Karsten Kuhn; Stefan Kienle; Josef Schwarz; Günter Schmidt; Thomas Neumann; R Johnstone; A Karim A Mohammed; Christian Hamon
Journal:  Anal Chem       Date:  2003-04-15       Impact factor: 6.986

2.  Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.

Authors:  Wan-Ming Li; Tao Bing; Jia-Yi Wei; Zhe-Zhou Chen; Di-Hua Shangguan; Jin Fang
Journal:  Biomaterials       Date:  2014-05-23       Impact factor: 12.479

Review 3.  Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.

Authors:  Martin Schlesinger; Gerd Bendas
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 4.  Cancer biomarker discovery: current status and future perspectives.

Authors:  Katrin Mäbert; Monica Cojoc; Claudia Peitzsch; Ina Kurth; Serhiy Souchelnytskyi; Anna Dubrovska
Journal:  Int J Radiat Biol       Date:  2014-05-12       Impact factor: 2.694

5.  Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.

Authors:  Dihua Shangguan; Zehui Charles Cao; Ying Li; Weihong Tan
Journal:  Clin Chem       Date:  2007-04-26       Impact factor: 8.327

6.  Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.

Authors:  Shao-En Ong; Blagoy Blagoev; Irina Kratchmarova; Dan Bach Kristensen; Hanno Steen; Akhilesh Pandey; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2002-05       Impact factor: 5.911

7.  Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery.

Authors:  Mingli Yang; Guohua Jiang; Wenjing Li; Kai Qiu; Min Zhang; Christopher M Carter; Samer Z Al-Quran; Ying Li
Journal:  J Hematol Oncol       Date:  2014-01-09       Impact factor: 17.388

8.  DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.

Authors:  Yuanyuan Wang; Yun Luo; Tao Bing; Zheng Chen; Minhua Lu; Nan Zhang; Dihua Shangguan; Xin Gao
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

9.  Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.

Authors:  J-K Jin; P-C Tien; C-J Cheng; J H Song; C Huang; S-H Lin; G E Gallick
Journal:  Oncogene       Date:  2014-05-05       Impact factor: 9.867

10.  Identification of cell membrane protein stress-induced phosphoprotein 1 as a potential ovarian cancer biomarker using aptamers selected by cell systematic evolution of ligands by exponential enrichment.

Authors:  Dimitri Van Simaeys; Diane Turek; Carole Champanhac; Julia Vaizer; Kwame Sefah; Jing Zhen; Rebecca Sutphen; Weihong Tan
Journal:  Anal Chem       Date:  2014-04-09       Impact factor: 6.986

View more
  10 in total

1.  Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology.

Authors:  Liqin Zhang; Shuo Wan; Ying Jiang; Yanyue Wang; Ting Fu; Qiaoling Liu; Zhijuan Cao; Liping Qiu; Weihong Tan
Journal:  J Am Chem Soc       Date:  2017-02-07       Impact factor: 15.419

2.  Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.

Authors:  Lin Li; Weili Miao; Ming Huang; Preston Williams; Yinsheng Wang
Journal:  Mol Cell Proteomics       Date:  2018-11-28       Impact factor: 5.911

3.  Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX.

Authors:  Guodong Wang; Jun Liu; Ke Chen; Yiling Xu; Bo Liu; Jie Liao; Lei Zhu; Xiaoxiao Hu; Jianglin Li; Ying Pu; Wen Zhong; Ting Fu; Huixia Liu; Weihong Tan
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

Review 4.  Aptamer selection and applications for breast cancer diagnostics and therapy.

Authors:  Mei Liu; Xiaocheng Yu; Zhu Chen; Tong Yang; Dandan Yang; Qianqian Liu; Keke Du; Bo Li; Zhifei Wang; Song Li; Yan Deng; Nongyue He
Journal:  J Nanobiotechnology       Date:  2017-11-13       Impact factor: 10.435

5.  Combined aptamer and transcriptome sequencing of single cells.

Authors:  Cyrille L Delley; Leqian Liu; Maen F Sarhan; Adam R Abate
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

Review 6.  Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers.

Authors:  Marie-Cécile Mercier; Monique Dontenwill; Laurence Choulier
Journal:  Cancers (Basel)       Date:  2017-06-21       Impact factor: 6.639

7.  CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.

Authors:  Wenting Jia; Caiping Ren; Lei Wang; Bin Zhu; Wei Jia; Menghui Gao; Fei Zeng; Liang Zeng; Xiaomeng Xia; Xiaobing Zhang; Ting Fu; Shasha Li; Can Du; Xingjun Jiang; Yuxiang Chen; Weihong Tan; Zilong Zhao; Weidong Liu
Journal:  Oncotarget       Date:  2016-08-23

Review 8.  Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.

Authors:  Xuehui Pang; Cheng Cui; Shuo Wan; Ying Jiang; Liangliang Zhang; Lian Xia; Long Li; Xiaowei Li; Weihong Tan
Journal:  Cancers (Basel)       Date:  2018-02-09       Impact factor: 6.639

9.  Aptameric Probe Specifically Binding Protein Heterodimer Rather Than Monomers.

Authors:  Tao Bing; Luyao Shen; Junyan Wang; Linlin Wang; Xiangjun Liu; Nan Zhang; Xiao Xiao; Dihua Shangguan
Journal:  Adv Sci (Weinh)       Date:  2019-04-09       Impact factor: 16.806

10.  DNA aptamers against bacterial cells can be efficiently selected by a SELEX process using state-of-the art qPCR and ultra-deep sequencing.

Authors:  Claudia Kolm; Isabella Cervenka; Ulrich J Aschl; Niklas Baumann; Stefan Jakwerth; Rudolf Krska; Robert L Mach; Regina Sommer; Maria C DeRosa; Alexander K T Kirschner; Andreas H Farnleitner; Georg H Reischer
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.